Unveiling the Relationship between Ceftobiprole and High-Molecular-Mass (HMM) Penicillin-Binding Proteins (PBPs) in <i>Enterococcus faecalis</i>

Low-affinity PBP4, historically linked to penicillin resistance in <i>Enterococcus faecalis</i>, may still have affinity for novel cephalosporins. Ceftobiprole (BPR) is a common therapeutic choice, even with PBP4-related overexpression and amino acid substitution due to mutations. Our st...

Full description

Saved in:
Bibliographic Details
Main Authors: Paola Conti (Author), Lorenzo Mattia Lazzaro (Author), Fabio Longo (Author), Federica Lenzo (Author), Alessandra Giardina (Author), Sebastiano Alberto Fortuna (Author), Stefania Stefani (Author), Floriana Campanile (Author)
Format: Book
Published: MDPI AG, 2024-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_8b4ece66653d468591b19f55bc22f36a
042 |a dc 
100 1 0 |a Paola Conti  |e author 
700 1 0 |a Lorenzo Mattia Lazzaro  |e author 
700 1 0 |a Fabio Longo  |e author 
700 1 0 |a Federica Lenzo  |e author 
700 1 0 |a Alessandra Giardina  |e author 
700 1 0 |a Sebastiano Alberto Fortuna  |e author 
700 1 0 |a Stefania Stefani  |e author 
700 1 0 |a Floriana Campanile  |e author 
245 0 0 |a Unveiling the Relationship between Ceftobiprole and High-Molecular-Mass (HMM) Penicillin-Binding Proteins (PBPs) in <i>Enterococcus faecalis</i> 
260 |b MDPI AG,   |c 2024-01-01T00:00:00Z. 
500 |a 10.3390/antibiotics13010065 
500 |a 2079-6382 
520 |a Low-affinity PBP4, historically linked to penicillin resistance in <i>Enterococcus faecalis</i>, may still have affinity for novel cephalosporins. Ceftobiprole (BPR) is a common therapeutic choice, even with PBP4-related overexpression and amino acid substitution due to mutations. Our study aims to explore the interaction between BPR and High-Molecular-Mass (HMM) low-reactive PBPs in Penicillin-Resistant-Ampicillin-Susceptible/Ceftobiprole Non-Susceptible (PRAS/BPR-NS) <i>E. faecalis</i> clinical isolates. We conducted competition assays examining class A and B HMM PBPs from four PRAS/BPR-NS <i>E. faecalis</i> strains using purified membrane proteins and fluorescent penicillin (Bocillin FL), in treated and untreated conditions. Interaction strength was assessed calculating the 50% inhibitory concentration (IC<sub>50</sub>) values for ceftobiprole, by analyzing fluorescence intensity trends. Due to its low affinity, PBP4 did not display significant acylation among all strains. Moreover, both PBP1a and PBP1b showed a similar insensitivity trend. Conversely, other PBPs showed IC<sub>50</sub> values ranging from 1/2-fold to 4-fold MICs. Upon higher BPR concentrations, increased percentages of PBP4 inhibition were observed in all strains. Our results support the hypothesis that PBP4 is necessary but not sufficient for BPR resistance, changing the paradigm for enterococcal cephalosporin resistance. We hypothesize that cooperation between class B PBP4 and at least one bifunctional class A PBP could be required to synthesize peptidoglycan and promote growth. 
546 |a EN 
690 |a <i>Enterococcus faecalis</i> 
690 |a ceftobiprole 
690 |a PBPs 
690 |a competition assays 
690 |a Bocillin 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Antibiotics, Vol 13, Iss 1, p 65 (2024) 
787 0 |n https://www.mdpi.com/2079-6382/13/1/65 
787 0 |n https://doaj.org/toc/2079-6382 
856 4 1 |u https://doaj.org/article/8b4ece66653d468591b19f55bc22f36a  |z Connect to this object online.